The association between LOC129390903 (MPRA-Validated Peak2919 Silencer) and Breast-Ovarian Cancer, Familial 3 is well established and manually curated, drawing on a single expert-curated source, which records pathogenic and likely-pathogenic variants.
Sources1
Clinical variants62
Symptoms2
Compounds0
Trials0
Publications6
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.